Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
SRCL Stock Summary
In the News

Reasons to Retain Stericycle (SRCL) Stock in Your Portfolio
Stericycle (SRCL) has strong customer relationships that ensure a steady flow of revenues.

Stericycle to Present at Baird 2023 Global Consumer, Technology and Services Conference in June
BANNOCKBURN, Ill., May 18, 2023 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today announced that Janet Zelenka, Chief Financial Officer and Chief Information Officer, will present at the Baird 2023 Global Consumer, Technology and Services Conference in New York on Thursday, June 8, 2023, and will participate in investor meetings along with Zabi Hotaki, Senior Vice President, Finance; and Andrew Ellis, Vice President Investor Relations and Enterprise Finance.

Stericycle's (SRCL) Q1 Earnings Beat Estimates, Surge Y/Y
Stericycle's (SRCL) first-quarter 2023 revenues increase year over year.

Stericycle (SRCL) Beats Q1 Earnings and Revenue Estimates
Stericycle (SRCL) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.32 per share a year ago.

Stericycle to Present at Oppenheimer 18th Annual Industrial Growth Conference in May
BANNOCKBURN, Ill., April 03, 2023 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today announced that Cindy J. Miller, Chief Executive Officer, and Janet Zelenka, Chief Financial Officer and Chief Information Officer, will present at Oppenheimer's virtual 18th Annual Industrial Growth Conference on Monday, May 8, 2023, and will participate in meetings with investors throughout the day.

Why Stericycle Stock Tanked This Week
A significant earnings miss and talk of a challenging business environment drove investors away from the shares.

Stericycle, Inc. (SRCL) Q4 2022 Earnings Call Transcript
Stericycle, Inc. (NASDAQ:SRCL ) Q4 2022 Earnings Conference Call February 23, 2023 9:00 AM ET Company Participants Andrew Ellis - Vice President of Investor Relations and Enterprise Finance Cindy Miller - President and Chief Executive Officer Janet Zelenka - Chief Financial Officer and Chief Information Officer Conference Call Participants Sean Dodge - RBC Capital Markets David Manthey - Baird Michael Hoffman - Stifel Scott Schneeberger - Oppenheimer Kevin Steinke - Barrington Research Operator Ladies and gentlemen. Hello and welcome to the Q4 2022 Stericycle Earnings Conference Call.

Stericycle (SRCL) Matches Q4 Earnings Estimates
Stericycle (SRCL) delivered earnings and revenue surprises of 0% and 3.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Stericycle (SRCL) Gains 19% in the Past 3 Months: Here's How
Stericycle (SRCL) has strong customer relationships, most of which include long-term contracts ranging from three to five years.

Why You Should Retain Stericycle (SRCL) in Your Portfolio Now
Stericycle (SRCL) is currently benefiting from its comprehensive multiyear Business Transformation as well as solid liquidity.
SRCL Financial details
SRCL Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 40.02 | 36.36 | 29.24 | 28.83 | 29.37 | |
Net income per share | -2.81 | -3.8 | -0.61 | -0.29 | 0.61 | |
Operating cash flow per share | 1.9 | 2.73 | 5.79 | 3.3 | 2.17 | |
Free cash flow per share | 0.4 | 0.59 | 4.49 | 2.03 | 0.74 | |
Cash per share | 0.39 | 0.38 | 0.58 | 0.61 | 0.61 | |
Book value per share | 29.71 | 25.61 | 26.56 | 26.13 | 26.28 | |
Tangible book value per share | -25.98 | -22.75 | -16.09 | -15 | -12.72 | |
Share holders equity per share | 29.71 | 25.61 | 26.56 | 26.13 | 26.28 | |
Interest debt per share | 33.18 | 35.53 | 24.56 | 22.31 | 21.77 | |
Market cap | 3.2B | 5.81B | 6.34B | 5.47B | 4.59B | |
Enterprise value | 5.94B | 8.89B | 8.46B | 7.4B | 6.47B | |
P/E ratio | -13.06 | -16.78 | -113.48 | -204.29 | 82.05 | |
Price to sales ratio | 0.92 | 1.75 | 2.37 | 2.07 | 1.7 | |
POCF ratio | 19.29 | 23.41 | 11.96 | 18.06 | 22.95 | |
PFCF ratio | 91.57 | 107.93 | 15.45 | 29.4 | 67.57 | |
P/B Ratio | 1.24 | 2.49 | 2.61 | 2.28 | 1.9 | |
PTB ratio | 1.24 | 2.49 | 2.61 | 2.28 | 1.9 | |
EV to sales | 1.71 | 2.69 | 3.16 | 2.79 | 2.39 | |
Enterprise value over EBITDA | 67.55 | 23.22 | 22.08 | 25.09 | 17.42 | |
EV to operating cash flow | 35.87 | 35.84 | 15.95 | 24.4 | 32.31 | |
EV to free cash flow | 170.33 | 165.19 | 20.59 | 39.72 | 95.12 | |
Earnings yield | -0.08 | -0.06 | -0.01 | 0 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.06 | 0.03 | 0.01 | |
Debt to equity | 1.49 | 1.76 | 1.3 | 1.28 | 1.2 | |
Debt to assets | 0.6 | 0.64 | 0.56 | 0.56 | 0.55 | |
Net debt to EBITDA | 31.24 | 8.05 | 5.51 | 6.52 | 5.05 | |
Current ratio | 1.02 | 0.93 | 0.79 | 0.79 | 0.9 | |
Interest coverage | -1.51 | 0.93 | 1.83 | 1.01 | 2.04 | |
Income quality | -0.68 | -0.72 | -9.48 | -11.31 | 3.54 | |
Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
Payout ratio | -0.1 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.34 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.75 | 0.68 | 0.7 | 0.69 | 0.67 | |
Capex to operating cash flow | -0.79 | -0.78 | -0.23 | -0.39 | -0.66 | |
Capex to revenue | -0.04 | -0.06 | -0.04 | -0.04 | -0.05 | |
Capex to depreciation | -0.51 | -0.71 | -0.51 | -0.52 | -0.57 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 43.33 | 46.81 | 19.11 | 13.1 | 18.96 | |
ROIC | -0.02 | 0.02 | 0.03 | -0.54 | 0.02 | |
Return on tangible assets | -0.15 | -0.17 | -0.03 | -0.02 | 0.03 | |
Graham Net | -38.74 | -40.21 | -30.7 | -29.41 | -27.61 | |
Working capital | 14.1M | -50.3M | -144.6M | -156.2M | -63.2M | |
Tangible asset value | -2.26B | -2.07B | -1.47B | -1.38B | -1.17B | |
Net current asset value | -3.11B | -3.4B | -2.6B | -2.49B | -2.35B | |
Invested capital | 1.08 | 1.34 | 0.89 | 0.82 | 0.8 | |
Average receivables | 611.85M | 571.95M | 462.5M | 400.55M | 417.45M | |
Average payables | 210.5M | 222.95M | 200.65M | 200.05M | 216.2M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 62.78 | 60.04 | 51.94 | 57.97 | 55.94 | |
Days payables outstanding | 39.06 | 37.64 | 40.77 | 49.03 | 46.41 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 5.81 | 6.08 | 7.03 | 6.3 | 6.53 | |
Payables turnover | 9.34 | 9.7 | 8.95 | 7.44 | 7.86 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.09 | -0.15 | -0.02 | -0.01 | 0.02 | |
Capex per share | -1.5 | -2.13 | -1.31 | -1.27 | -1.44 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 7.22 | 7.38 | 7.49 | 7.27 | 7.41 | |
Net income per share | -0.15 | 0.11 | 0.3 | 0.34 | 0.12 | |
Operating cash flow per share | -0.42 | 0.22 | 0.67 | 1.7 | 0.54 | |
Free cash flow per share | -0.83 | -0.13 | 0.28 | 1.42 | 0.14 | |
Cash per share | 0.65 | 0.5 | 0.48 | 0.61 | 0.65 | |
Book value per share | 25.84 | 25.51 | 25.19 | 26.25 | 26.49 | |
Tangible book value per share | -14.79 | -14.31 | -13.7 | -12.71 | -12.21 | |
Share holders equity per share | 25.84 | 25.51 | 25.19 | 26.25 | 26.49 | |
Interest debt per share | 22.6 | 22.69 | 22.69 | 21.15 | 21.25 | |
Market cap | 5.42B | 4.04B | 3.88B | 4.6B | 4.03B | |
Enterprise value | 7.42B | 6.06B | 5.91B | 6.47B | 5.91B | |
P/E ratio | -96.11 | 96.16 | 34.67 | 36.16 | 89.85 | |
Price to sales ratio | 8.16 | 5.94 | 5.62 | 6.86 | 5.88 | |
POCF ratio | -139.71 | 197.97 | 63.13 | 29.28 | 81.32 | |
PFCF ratio | -71.04 | -333.77 | 152.26 | 35.14 | 307.27 | |
P/B Ratio | 2.28 | 1.72 | 1.67 | 1.9 | 1.65 | |
PTB ratio | 2.28 | 1.72 | 1.67 | 1.9 | 1.65 | |
EV to sales | 11.18 | 8.92 | 8.56 | 9.66 | 8.63 | |
Enterprise value over EBITDA | 114.57 | 63.7 | 52.96 | 149.15 | 59.06 | |
EV to operating cash flow | -191.35 | 297.26 | 96.11 | 41.2 | 119.31 | |
EV to free cash flow | -97.3 | -501.16 | 231.79 | 49.45 | 450.83 | |
Earnings yield | 0 | 0 | 0.01 | 0.01 | 0 | |
Free cash flow yield | -0.01 | 0 | 0.01 | 0.03 | 0 | |
Debt to equity | 1.3 | 1.3 | 1.3 | 1.2 | 1.18 | |
Debt to assets | 0.57 | 0.56 | 0.56 | 0.55 | 0.54 | |
Net debt to EBITDA | 30.92 | 21.28 | 18.17 | 43.17 | 18.81 | |
Current ratio | 0.92 | 0.96 | 1.02 | 0.9 | 0.97 | |
Interest coverage | 0.36 | 2.06 | 2.56 | -0.62 | 1.96 | |
Income quality | 2.75 | 1.94 | 2.2 | 4.89 | 4.38 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.68 | 0.68 | 0.67 | 0.67 | 0.67 | |
Capex to operating cash flow | 0.97 | -1.59 | -0.59 | -0.17 | -0.74 | |
Capex to revenue | -0.06 | -0.05 | -0.05 | -0.04 | -0.05 | |
Capex to depreciation | -0.63 | -0.56 | -0.61 | -0.47 | -0.66 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 9.44 | 8.09 | 13.12 | 14.27 | 8.5 | |
ROIC | 0 | 0 | 0.01 | 0 | 0 | |
Return on tangible assets | -0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
Graham Net | -29.27 | -28.87 | -28.45 | -27.58 | -27.21 | |
Working capital | -56M | -21.7M | 10.9M | -63.2M | -16.8M | |
Tangible asset value | -1.36B | -1.32B | -1.26B | -1.17B | -1.13B | |
Net current asset value | -2.48B | -2.46B | -2.42B | -2.35B | -2.32B | |
Invested capital | 0.87 | 0.88 | 0.89 | 0.8 | 0.79 | |
Average receivables | 438.8M | 461.7M | 464.8M | 438.95M | 417M | |
Average payables | 214.9M | 209M | 203.75M | 206.95M | 204.4M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 61.95 | 61.72 | 60.42 | 55.65 | 55.17 | |
Days payables outstanding | 45.23 | 44.45 | 42.53 | 46.19 | 41.52 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 1.45 | 1.46 | 1.49 | 1.62 | 1.63 | |
Payables turnover | 1.99 | 2.02 | 2.12 | 1.95 | 2.17 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.01 | 0 | 0.01 | 0.01 | 0 | |
Capex per share | -0.41 | -0.35 | -0.39 | -0.28 | -0.39 |
SRCL Frequently Asked Questions
What is Stericycle, Inc. stock symbol ?
Stericycle, Inc. is a US stock , located in Bannockburn of Il and trading under the symbol SRCL
Is Stericycle, Inc. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $45. The lowest prediction is $45 and the highest is $45
What is SRCL stock prediction ?
With a median analyst target price of $45, 1 stock analysts have made 1 forecasts in last 90 days. $45 is the lowest and $45 is the greatest projection.
What is Stericycle, Inc. stock quote today ?
Stericycle, Inc. stock price is $43.04 today.
Is Stericycle, Inc. stock public?
Yes, Stericycle, Inc. is a publicly traded company.